Skip to content

Effect of Balachaturbhadra Churna & Arvindasava in the Management of Jeerna Balatisara (Chronic Non Specific Diarrhoea in Children)

Clinical evaluation of the effect of Balachaturbhadra Churna & Arvindasava in the management of Jeerna Balatisara (Chronic Non Specific Diarrhoea in Children) - IMCRP â?? Jeerna Balatisara

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/07/019997
Enrollment
120
Registered
2019-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K529- Noninfective gastroenteritis and colitis, unspecified

Interventions

Intervention1: Balachaturbhadra Churna and Arvindasava: Composition / constituents ofBalachaturbhadra Churna 1. Ghana (Musta) Cyperus rotundus Root Tuber 2. Krsna (Pippali) Piper longum Fruit 3.

Sponsors

Central Council for Research in Ayurvedic Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients of either sex with age between 3 to 5 years 2.Patients of Non Specific Chronic diarrhea fulfilling Rome IV criteria, which is as follows: a)Passage of large unformed stools, three or more times a day, daily, painless for more than 4 weeks. b)Onset of symptoms begins between 6 and 60 months of age. c)Passage of stools occurs during waking hours. d)There is no failure to thrive, if caloric intake is adequate. 3.Willing and able to participate (consent to be obtained from Parent(s) / Guardian(s)/ Assent from children wherever possible).

Exclusion criteria

Exclusion criteria: 1.Known case of acute diarrhea (history 2.Patients with bleeding per rectum. 3.Patients suffering from any systemic illness affecting the bowel habits. 4.Children with abnormal laboratory values at admission in to the study: serum creatinine > 0.7 (mg/dl); AST >25(U/L); ALT >29(U/L) ; Alkaline phosphatase > 391 (U/L) and any other condition which the investigator thinks may jeopardize the study.

Design outcomes

Secondary

MeasureTime frame
Pediatric Quality of Life InventoryTimepoint: Base line 7th Day 14th Day

Primary

MeasureTime frame
1. Change in frequency of stools. 2.Changes in consistency of stools assessed by using Bristol stool chart.Timepoint: Base line 7th Day 14th Day

Countries

India

Contacts

Public ContactDr Savita Sharma

Regional Ayurveda Research Institute for Mother and Child Health

savitashirish@yahoo.co.in9422823964

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026